M&A Deal Summary |
|
|---|---|
| Date | 2024-01-03 |
| Target | MenoLabs |
| Sector | Healthcare Services |
| Buyer(s) | Dr. Reddy s Laboratories |
| Sellers(s) | Amyris |
| Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1984 |
| Sector | Medical Products |
| Employees | 22,739 |
| Revenue | 279.2B INR (2024) |
Dr. Reddy’s Laboratories is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets. Dr. Reddy's Laboratories was founded in 1984 and is based in Hyderabad, India
| DEAL STATS | # |
|---|---|
| Overall | 6 of 6 |
| Sector (Healthcare Services) | 1 of 1 |
| Type (Divestiture) | 3 of 3 |
| State (Arizona) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-03 |
Nimbus Health
Offenbach, Germany Nimbus Health is a pharmaceutical wholesaler and manufacturer with its own warehouse facilities and an independent sales force to promote medical cannabis-based products to pharmacists. The Company's mission is to supply seriously ill patients with the highest grade medical cannabis products from reliable sources consistently and sustainably. Nimbus Health was founded in 2018 and is based in Offenbach, Germany. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Life Science |
| Employees | 1,598 |
| Revenue | 270M USD (2022) |
Amyris is an integrated renewable products company that enables the brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. Amyris was founded in 2003 and is based in Emeryville, California.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector (Healthcare Services) | 1 of 1 |
| Type (Divestiture) | 3 of 3 |
| State (Arizona) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-02-22 |
Amyris - Cosmetic Ingredients
Emeryville, California, United States Amyris's Cosmetic Ingredients including Neossance® Squalane, the highest performant emollient, Neossance® Hemisqualane, the plant-based silicone alternative and CleanScreen, the sustainable sun protector. |
Sell | - |
